PPARA and Hepatic fibrosis: Moreover, we suggest that the clinical efficacy of antifibrotic drugs related to lipid metabolites (polyene phosphatidylcholine, PPAR synthetic ligand thiazolidinediones) and whether lipid metabolites can be used as biomarkers for predicting the severity of hepatic fibrosis should be further explored.